Knuff & CO LLC Abb Vie Inc. Transaction History

Knuff & CO LLC

$323 Million
Q3 2024

A detailed history of Knuff & CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Knuff & CO LLC holds 7,775 shares of ABBV stock, worth $1.37 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

7,775

Previous 7,875 1.27%

Holding current value

$1.37 Million

Previous $1.35 Million 13.7%

% of portfolio

0.48%

Previous 0.44%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $16,384 - $19,933	-100 Reduced 1.27%	7,775 $1.54 Million
Q2 2024 Aug 01, 2024	SELL	$154.79 - $180.76 $23,218 - $27,114	-150 Reduced 1.87%	7,875 $1.35 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $20,038 - $23,197	-150 Reduced 1.83%	8,025 $1.2 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $79,506 - $98,940	-600 Reduced 6.84%	8,175 $1.1 Million
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $723 - $832	5 Added 0.06%	8,775 $1.4 Million
Q4 2022 Feb 09, 2023	SELL	$138.31 - $165.87 $20,746 - $24,880	-150 Reduced 1.68%	8,770 $1.42 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $90,591 - $103,902	-675 Reduced 7.03%	8,920 $1.2 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $35,370 - $43,885	268 Added 2.87%	9,595 $1.56 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $62,309 - $78,839	-580 Reduced 5.85%	9,327 $1.26 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $1,596 - $1,811	-15 Reduced 0.15%	9,907 $1.07 Million
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $2,557 - $2,815	-25 Reduced 0.25%	9,922 $1.07 Million
Q4 2020 Feb 03, 2021	BUY	$80.49 - $108.67 $10,222 - $13,801	127 Added 1.29%	9,947 $1.07 Million
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $29,209 - $34,282	340 Added 3.59%	9,820 $860,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $111,889 - $149,724	1,525 Added 19.17%	9,480 $931,000
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $31,605 - $47,917	490 Added 6.56%	7,955 $606,000
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $11,966 - $14,386	190 Added 2.61%	7,465 $565,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $9,198 - $11,757	140 Added 1.96%	7,275 $529,000
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $30,856 - $36,316	400 Added 5.94%	7,135 $575,000
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $524,319 - $646,627	6,735 New	6,735 $621,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knuff & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knuff & CO LLC with notifications on news.

Account